Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Regulatory News:
Orexo (STO:ORX)
Unless otherwise stated in this report, all data refers to the Group. Figures in parentheses relate to the corresponding period in 2012.
The transition to a commercial and profitable pharmaceutical company continues
During the period
•Net revenues amounted to MSEK 139.8 (83.6).
Help employers find you! Check out all the jobs and post your resume.
Regulatory News:
Orexo (STO:ORX)
Unless otherwise stated in this report, all data refers to the Group. Figures in parentheses relate to the corresponding period in 2012.
The transition to a commercial and profitable pharmaceutical company continues
During the period
•Net revenues amounted to MSEK 139.8 (83.6).
Help employers find you! Check out all the jobs and post your resume.
